BFM
ELTX icon

Boothbay Fund Management’s Elicio Therapeutics ELTX Stock Holding History

Boothbay Fund Management’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
+32,400
New +$325K ﹤0.01% 2016

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Boothbay Fund Management's ELTX Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 30,690 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #2028 among its holdings.

48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Boothbay Fund Management held 30,690 shares of Elicio Therapeutics worth $120K as of Q2 2026.
  • Elicio Therapeutics was a new Boothbay Fund Management position in Q2 2026.
  • Elicio Therapeutics made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2028 holding.
  • 48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.